Literature DB >> 1899623

Activation of human monocytes by granulocyte-macrophage colony-stimulating factor: increased urokinase-type plasminogen activator activity.

P H Hart1, G F Vitti, D R Burgess, G A Whitty, K Royston, J A Hamilton.   

Abstract

Granulocyte-macrophage colony-stimulating factor (GM-CSF) raised the plasminogen activator (PA) activity of cultured human monocytes. This activity was characterized to be urokinase-PA (u-PA) by incubation with specific IgG and by sodium dodecyl sulfate-polyacrylamide gel electrophoresis zymography. Increased u-PA activity reflected GM-CSF-induction of u-PA mRNA levels. The stimulatory properties of GM-CSF for monocyte PA activity differed from those of interleukin-4, which induced monocyte tissue-type PA (t-PA) activity, and of interferon-gamma (IFN-gamma), which alone was not stimulatory but augmented lipopolysaccharide-induced t-PA activity. GM-CSF alone did not stimulate detectable monocyte t-PA activity but combined with IFN-gamma to promote this activity. Plasmin formation arising from GM-CSF-induced u-PA in monocytes may contribute to the matrix turnover involved in, eg, cell migration and inflammation, and may explain some of the pathology seen in GM-CSF transgenic mice.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1899623

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

1.  Granulocyte-macrophage colony-stimulating factor modulates lipopolysaccharide (LPS)-binding and LPS-response of human macrophages: inverse regulation of tumour necrosis factor-alpha and interleukin-10.

Authors:  M Kreutz; B Hennemann; U Ackermann; E Grage-Griebenow; S W Krause; R Andreesen
Journal:  Immunology       Date:  1999-12       Impact factor: 7.397

2.  GM-CSF and uPA are required for Porphyromonas gingivalis-induced alveolar bone loss in a mouse periodontitis model.

Authors:  Roselind S Lam; Neil M O'Brien-Simpson; John A Hamilton; Jason C Lenzo; James A Holden; Gail C Brammar; Rebecca K Orth; Yan Tan; Katrina A Walsh; Andrew J Fleetwood; Eric C Reynolds
Journal:  Immunol Cell Biol       Date:  2015-03-10       Impact factor: 5.126

3.  Interleukin-4 suppresses granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor levels in stimulated human monocytes.

Authors:  J A Hamilton; G A Whitty; A K Royston; J Cebon; J E Layton
Journal:  Immunology       Date:  1992-08       Impact factor: 7.397

4.  G-CSF increases secretion of urokinase-type plasminogen activator by human lung cancer cells.

Authors:  X H Pei; Y Nakanishi; K Takayama; F Bai; M Kawasaki; N Hara
Journal:  Clin Exp Metastasis       Date:  1998-08       Impact factor: 5.150

5.  Mavrilimumab, a human monoclonal antibody targeting GM-CSF receptor-α, in subjects with rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase I, first-in-human study.

Authors:  Gerd R Burmester; Eugen Feist; Matthew A Sleeman; Bing Wang; Barbara White; Fabio Magrini
Journal:  Ann Rheum Dis       Date:  2011-05-25       Impact factor: 19.103

6.  Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease.

Authors:  A D Cook; E L Braine; I K Campbell; M J Rich; J A Hamilton
Journal:  Arthritis Res       Date:  2001-06-11

7.  Granulocyte, granulocyte-macrophage, and macrophage colony-stimulating factors can stimulate the invasive capacity of human lung cancer cells.

Authors:  X H Pei; Y Nakanishi; K Takayama; F Bai; N Hara
Journal:  Br J Cancer       Date:  1999-01       Impact factor: 7.640

Review 8.  Profile of Matrix-Remodeling Proteinases in Osteoarthritis: Impact of Fibronectin.

Authors:  Selene Pérez-García; Mar Carrión; Irene Gutiérrez-Cañas; Raúl Villanueva-Romero; David Castro; Carmen Martínez; Isidoro González-Álvaro; Francisco J Blanco; Yasmina Juarranz; Rosa P Gomariz
Journal:  Cells       Date:  2019-12-22       Impact factor: 6.600

9.  Increased Interleukin-35 suppresses peripheral CD14+ monocytes function in patients with Kawasaki disease.

Authors:  Haijian Xing; Gang Tian
Journal:  BMC Immunol       Date:  2020-04-10       Impact factor: 3.615

10.  Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers.

Authors:  J Taylor-Wiedeman; P Sissons; J Sinclair
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.